Ulys, L.L.C. — Inside Their 13F Portfolio

CIK: 0001340098

Concentrated strategy

Total reported value

$25.4M

Reporting period: 2021-03-31 · Number of holdings: 1

Ulys, L.L.C. disclosed 1 holdings in its latest 13F filing for the period ending 2021-03-31, with total reported value of $25.4M and a quarterly turnover rate of 52.7%.

Browse other institutions with under $100M AUM Browse other institutions starting with "U"

Personality snowflake

Concentration: 100
Portfolio Stability: 52.74
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 2
Sizing Uniformity: —

Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.

Recent moves

Unchanged LXRX
0.0%　$10.6M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change	4Q Trend
1	LXRX	Lexicon Pharmaceuticals INC	Stock-Other	100.00%	—	—

Portfolio Performance

Not enough priced holdings yet to compute performance

Reported value over time

Sector allocation

Not enough sector-mapped data yet

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2021-03-31	1	$25.4M	53	1LXRX Top holdings2021-03-31 1.LXRX
2020-12-31	1	$14.8M	81	1LXRX Top holdings2020-12-31 1.LXRX
2020-09-30	1	$6.2M	32	1LXRX Top holdings2020-09-30 1.LXRX
2020-06-30	1	$8.6M	2	1LXRX Top holdings2020-06-30 1.LXRX
2020-03-31	1	$8.4M	72	1LXRX Top holdings2020-03-31 1.LXRX
2019-12-31	1	$17.9M	32	1LXRX Top holdings2019-12-31 1.LXRX
2019-09-30	1	$13.0M	71	1LXRX Top holdings2019-09-30 1.LXRX
2019-06-30	1	$27.2M	12	1LXRX Top holdings2019-06-30 1.LXRX
2019-03-31	1	$24.0M	18	1LXRX Top holdings2019-03-31 1.LXRX
2018-12-31	1	$28.7M	47	1LXRX Top holdings2018-12-31 1.LXRX
2018-09-30	1	$46.1M	12	1LXRX Top holdings2018-09-30 1.LXRX
2018-06-30	1	$51.9M	33	1LXRX Top holdings2018-06-30 1.LXRX
2018-03-31	1	$37.0M	14	1LXRX Top holdings2018-03-31 1.LXRX
2017-12-31	1	$42.7M	22	1LXRX Top holdings2017-12-31 1.LXRX
2017-09-30	1	$53.1M	29	1LXRX Top holdings2017-09-30 1.LXRX
2017-06-30	1	$71.1M	14	1LXRX Top holdings2017-06-30 1.LXRX
2017-03-31	1	$62.0M	4	1LXRX Top holdings2017-03-31 1.LXRX
2016-12-31	1	$59.8M	27	1LXRX Top holdings2016-12-31 1.LXRX
2016-09-30	1	$78.1M	23	1LXRX Top holdings2016-09-30 1.LXRX
2016-06-30	2	$62.0M	18	1LXRX2156773 Top holdings2016-06-30 1.LXRX 2.156773
2016-03-31	2	$51.6M	11	1LXRX2156773 Top holdings2016-03-31 1.LXRX 2.156773
2015-12-31	2	$57.5M	21	1LXRX2156773 Top holdings2015-12-31 1.LXRX 2.156773
2015-09-30	2	$46.4M	29	1LXRX2156773 Top holdings2015-09-30 1.LXRX 2.156773
2015-06-30	2	$34.8M	100	1LXRX2156773 Top holdings2015-06-30 1.LXRX 2.156773
2015-03-31	2	$28.4M	3	15288722156773 Top holdings2015-03-31 1.528872 2.156773
2014-12-31	2	$27.5M	42	15288722156773 Top holdings2014-12-31 1.528872 2.156773
2014-09-30	2	$42.0M	13	15288722156773 Top holdings2014-09-30 1.528872 2.156773
2014-06-30	2	$48.0M	7	15288722156773 Top holdings2014-06-30 1.528872 2.156773
2014-03-31	2	$51.6M	4	15288722156773 Top holdings2014-03-31 1.528872 2.156773
2013-12-31	2	$53.7M	28	15288722156773 Top holdings2013-12-31 1.528872 2.156773
2013-09-30	2	$70.9M	9	15288722156773 Top holdings2013-09-30 1.528872 2.156773
2013-06-30	2	$64.7M	0	15288722156773 Top holdings2013-06-30 1.528872 2.156773

Holding changes this quarter

Position changes disclosed by Ulys, L.L.C. for the quarter ending 2021-03-31, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	LXRX	Lexicon Pharmaceuticals INC	—	—	Unchanged

Filing History

Period	Filed	Type	EDGAR
2021-03-31	2021-05-14	13F-HR	View on EDGAR
2020-12-31	2021-02-11	13F-HR	View on EDGAR
2020-09-30	2020-11-13	13F-HR	View on EDGAR
2020-06-30	2020-08-14	13F-HR	View on EDGAR
2020-03-31	2020-05-14	13F-HR	View on EDGAR
2019-12-31	2020-02-13	13F-HR	View on EDGAR
2019-09-30	2019-11-14	13F-HR	View on EDGAR
2019-06-30	2019-08-09	13F-HR	View on EDGAR
2019-03-31	2019-05-13	13F-HR	View on EDGAR
2018-12-31	2019-02-11	13F-HR	View on EDGAR
2018-09-30	2018-11-09	13F-HR	View on EDGAR
2018-06-30	2018-08-10	13F-HR	View on EDGAR
2018-03-31	2018-05-10	13F-HR	View on EDGAR
2017-12-31	2018-02-09	13F-HR	View on EDGAR
2017-09-30	2017-11-08	13F-HR	View on EDGAR
2017-06-30	2017-08-11	13F-HR	View on EDGAR
2017-03-31	2017-05-15	13F-HR	View on EDGAR
2016-12-31	2017-02-14	13F-HR	View on EDGAR
2016-09-30	2016-11-14	13F-HR	View on EDGAR
2016-06-30	2016-08-11	13F-HR	View on EDGAR
2016-03-31	2016-05-12	13F-HR	View on EDGAR
2015-12-31	2016-02-12	13F-HR	View on EDGAR
2015-09-30	2015-11-13	13F-HR	View on EDGAR
2015-06-30	2015-08-13	13F-HR	View on EDGAR
2015-03-31	2015-05-13	13F-HR	View on EDGAR
2014-12-31	2015-02-12	13F-HR	View on EDGAR
2014-09-30	2014-11-13	13F-HR	View on EDGAR
2014-06-30	2014-08-14	13F-HR	View on EDGAR
2014-03-31	2014-05-15	13F-HR	View on EDGAR
2013-12-31	2014-02-14	13F-HR	View on EDGAR
2013-09-30	2013-11-14	13F-HR	View on EDGAR
2013-06-30	2013-08-09	13F-HR	View on EDGAR

FAQ

What is Ulys, L.L.C. and what type of investor is it?

Ulys, L.L.C. is an investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2021-03-31), the firm manages a tracked equity portfolio valued at approximately $25.4M, spread across 1 disclosed positions.

What are Ulys, L.L.C.'s largest equity positions?

Based on the latest 13F filing, Ulys, L.L.C.'s top holdings by market value are: 1. Lexicon Pharmaceuticals INC (LXRX) — $25.4M (100.0%)

What changes did Ulys, L.L.C. make in its most recent portfolio filing?

No notable portfolio changes were recorded for Ulys, L.L.C. in the most recent quarter. Holdings appear to have remained relatively stable.

What sectors does Ulys, L.L.C. focus on?

Sector breakdown data is not yet available for Ulys, L.L.C.. Check back after the next 13F processing cycle.

Peer Institutions

Institutions with a similar AUM

Top Ace Asset Management Ltd

CIK 0001614200

Total reported value

$25.3M

10 stks

2023-09-30

Stale — no recent filing

Concentration90.1

Portfolio Stability0.0

Sector conviction100.0

AUM within 0.1% of this institution

View detail

BTG Pactual Asset Management S.A. DTVM

CIK 0001569785

Total reported value

$25.4M

15 stks

2015-12-31

Stale — no recent filing

Concentration41.6

Portfolio Stability100.0

Sector conviction77.8

AUM within 0.2% of this institution

View detail

Vahanian & Associates Financial Planning Inc.

CIK 0001900990

Total reported value

$25.3M

50 stks

2023-12-31

Stale — no recent filing

Concentration17.4

Portfolio Stability0.0

Sector conviction100.0

AUM within 0.3% of this institution

View detail

Similar Holdings Style

Institutions with overlapping top holdings

Artal Group S.A.

CIK 0001053906

Total reported value

$1.0B

2 stks

2026-03-31

Concentration100.0

Portfolio Stability34.3

Sector conviction100.0

1 of the top 5 holdings overlap, including Lexicon Pharmaceuticals INC

View detail

Personality snowflake

Concentration

100

Portfolio Stability

52.74

Momentum/Contrarian

Sector conviction

Diversification

Sizing Uniformity

—

Full holdings list this quarter

Ticker

Issuer

Asset Subclass

Weight

Weight Change

Shares Change

4Q Trend

LXRX

Lexicon Pharmaceuticals INC

Stock-Other

100.00%

—

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2021-03-31	1	$25.4M	53	1LXRX Top holdings2021-03-31 1.LXRX
2020-12-31	1	$14.8M	81	1LXRX Top holdings2020-12-31 1.LXRX
2020-09-30	1	$6.2M	32	1LXRX Top holdings2020-09-30 1.LXRX
2020-06-30	1	$8.6M	2	1LXRX Top holdings2020-06-30 1.LXRX
2020-03-31	1	$8.4M	72	1LXRX Top holdings2020-03-31 1.LXRX
2019-12-31	1	$17.9M	32	1LXRX Top holdings2019-12-31 1.LXRX
2019-09-30	1	$13.0M	71	1LXRX Top holdings2019-09-30 1.LXRX
2019-06-30	1	$27.2M	12	1LXRX Top holdings2019-06-30 1.LXRX
2019-03-31	1	$24.0M	18	1LXRX Top holdings2019-03-31 1.LXRX
2018-12-31	1	$28.7M	47	1LXRX Top holdings2018-12-31 1.LXRX
2018-09-30	1	$46.1M	12	1LXRX Top holdings2018-09-30 1.LXRX
2018-06-30	1	$51.9M	33	1LXRX Top holdings2018-06-30 1.LXRX
2018-03-31	1	$37.0M	14	1LXRX Top holdings2018-03-31 1.LXRX
2017-12-31	1	$42.7M	22	1LXRX Top holdings2017-12-31 1.LXRX
2017-09-30	1	$53.1M	29	1LXRX Top holdings2017-09-30 1.LXRX
2017-06-30	1	$71.1M	14	1LXRX Top holdings2017-06-30 1.LXRX
2017-03-31	1	$62.0M	4	1LXRX Top holdings2017-03-31 1.LXRX
2016-12-31	1	$59.8M	27	1LXRX Top holdings2016-12-31 1.LXRX
2016-09-30	1	$78.1M	23	1LXRX Top holdings2016-09-30 1.LXRX
2016-06-30	2	$62.0M	18	1LXRX2156773 Top holdings2016-06-30 1.LXRX 2.156773
2016-03-31	2	$51.6M	11	1LXRX2156773 Top holdings2016-03-31 1.LXRX 2.156773
2015-12-31	2	$57.5M	21	1LXRX2156773 Top holdings2015-12-31 1.LXRX 2.156773
2015-09-30	2	$46.4M	29	1LXRX2156773 Top holdings2015-09-30 1.LXRX 2.156773
2015-06-30	2	$34.8M	100	1LXRX2156773 Top holdings2015-06-30 1.LXRX 2.156773
2015-03-31	2	$28.4M	3	15288722156773 Top holdings2015-03-31 1.528872 2.156773
2014-12-31	2	$27.5M	42	15288722156773 Top holdings2014-12-31 1.528872 2.156773
2014-09-30	2	$42.0M	13	15288722156773 Top holdings2014-09-30 1.528872 2.156773
2014-06-30	2	$48.0M	7	15288722156773 Top holdings2014-06-30 1.528872 2.156773
2014-03-31	2	$51.6M	4	15288722156773 Top holdings2014-03-31 1.528872 2.156773
2013-12-31	2	$53.7M	28	15288722156773 Top holdings2013-12-31 1.528872 2.156773
2013-09-30	2	$70.9M	9	15288722156773 Top holdings2013-09-30 1.528872 2.156773
2013-06-30	2	$64.7M	0	15288722156773 Top holdings2013-06-30 1.528872 2.156773

Ticker

Issuer

Weight Change

Shares Change

Action

LXRX

Lexicon Pharmaceuticals INC

—

Unchanged

Filing History

Period	Filed	Type	EDGAR
2021-03-31	2021-05-14	13F-HR	View on EDGAR
2020-12-31	2021-02-11	13F-HR	View on EDGAR
2020-09-30	2020-11-13	13F-HR	View on EDGAR
2020-06-30	2020-08-14	13F-HR	View on EDGAR
2020-03-31	2020-05-14	13F-HR	View on EDGAR
2019-12-31	2020-02-13	13F-HR	View on EDGAR
2019-09-30	2019-11-14	13F-HR	View on EDGAR
2019-06-30	2019-08-09	13F-HR	View on EDGAR
2019-03-31	2019-05-13	13F-HR	View on EDGAR
2018-12-31	2019-02-11	13F-HR	View on EDGAR
2018-09-30	2018-11-09	13F-HR	View on EDGAR
2018-06-30	2018-08-10	13F-HR	View on EDGAR
2018-03-31	2018-05-10	13F-HR	View on EDGAR
2017-12-31	2018-02-09	13F-HR	View on EDGAR
2017-09-30	2017-11-08	13F-HR	View on EDGAR
2017-06-30	2017-08-11	13F-HR	View on EDGAR
2017-03-31	2017-05-15	13F-HR	View on EDGAR
2016-12-31	2017-02-14	13F-HR	View on EDGAR
2016-09-30	2016-11-14	13F-HR	View on EDGAR
2016-06-30	2016-08-11	13F-HR	View on EDGAR
2016-03-31	2016-05-12	13F-HR	View on EDGAR
2015-12-31	2016-02-12	13F-HR	View on EDGAR
2015-09-30	2015-11-13	13F-HR	View on EDGAR
2015-06-30	2015-08-13	13F-HR	View on EDGAR
2015-03-31	2015-05-13	13F-HR	View on EDGAR
2014-12-31	2015-02-12	13F-HR	View on EDGAR
2014-09-30	2014-11-13	13F-HR	View on EDGAR
2014-06-30	2014-08-14	13F-HR	View on EDGAR
2014-03-31	2014-05-15	13F-HR	View on EDGAR
2013-12-31	2014-02-14	13F-HR	View on EDGAR
2013-09-30	2013-11-14	13F-HR	View on EDGAR
2013-06-30	2013-08-09	13F-HR	View on EDGAR

FAQ

What is Ulys, L.L.C. and what type of investor is it?

What are Ulys, L.L.C.'s largest equity positions?

Based on the latest 13F filing, Ulys, L.L.C.'s top holdings by market value are: 1. Lexicon Pharmaceuticals INC (LXRX) — $25.4M (100.0%)

What changes did Ulys, L.L.C. make in its most recent portfolio filing?

No notable portfolio changes were recorded for Ulys, L.L.C. in the most recent quarter. Holdings appear to have remained relatively stable.

What sectors does Ulys, L.L.C. focus on?

Sector breakdown data is not yet available for Ulys, L.L.C.. Check back after the next 13F processing cycle.